SHANGHAI, Nov. 21, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and […]
Tag: Pharmaceuticals
Capital Rx Achieves Place on the Deloitte Technology Fast 500™ for Third Year in a Row
Capital Rx ranks #147 on the 2024 Deloitte Fast 500, the list of North America’s fastest-growing companies NEW YORK, Nov. 21, 2024 /PRNewswire/ — Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator […]
Aizen Therapeutics advances Mirror Peptides as new drug class
Caltech AI professor and biotech veterans secure $13M in venture capital to create new category of biologic medicine SAN DIEGO, Nov. 21, 2024 /PRNewswire/ — Aizen Therapeutics, an AI-driven biotechnology company, today emerged from stealth […]
Nouvelle alliance pour le développement d’une formulation sublinguale d’ocytocine destinée à prévenir les hémorragies du post-partum
Les résultats de l’essai clinique pourraient aider à sauver la vie de plus de 70 000 femmes enceintes dans le monde chaque année Selon l’Organisation mondiale de la santé (OMS), l’hémorragie puerpérale ou post-partum (HPP) est l’une […]
Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2+ BTC in the U.S. Ziihera received accelerated approval based on results including a 52% objective response rate and median duration of response […]